Profile
Jonathan Burgin's current job is as the Chief Executive Officer at BioCancell Therapeutics, Inc. He previously held positions as the Director-Investor Relations at XTL Biopharmaceuticals Ltd., Independent Director at Cellect Biotechnology Ltd., Chief Financial Officer at RADCOM Ltd., Chief Operating Officer at Anchiano Therapeutics Ltd., and Senior Manager at Kesselman & Kesselman.
Prior to these roles, he was a Member at PricewaterhouseCoopers International Ltd. and Chief Financial Officer at Y.L.R.
Capital Markets Ltd. Mr. Burgin obtained his undergraduate degree and MBA from Tel-Aviv University.
Jonathan Burgin active positions
| Companies | Position | Start |
|---|---|---|
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology Is a biopharmaceuticals company | Chief Executive Officer | 03/06/2012 |
Former positions of Jonathan Burgin
| Companies | Position | End |
|---|---|---|
| ANCHIANO THERAPEUTICS LTD | Chief Executive Officer | 18/10/2016 |
| RADCOM LTD. | Director of Finance/CFO | 20/05/2011 |
| XTL BIOPHARMACEUTICALS LTD. | Public Communications Contact | 31/12/2005 |
Y.L.R. Capital Markets Ltd. | Director of Finance/CFO | 31/12/1998 |
PricewaterhouseCoopers International Ltd.
PricewaterhouseCoopers International Ltd. Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax, legal, consulting and risk management services | Corporate Officer/Principal | - |
Training of Jonathan Burgin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
RADCOM Ltd.
RADCOM Ltd. Packaged SoftwareTechnology Services Provides software solutions for telecommunication companies | Technology Services |
Anchiano Therapeutics Ltd.
Anchiano Therapeutics Ltd. BiotechnologyHealth Technology Provides biopharmaceutical services | Health Technology |
XTL Biopharmaceuticals Ltd.
XTL Biopharmaceuticals Ltd. Medical SpecialtiesHealth Technology Develops pharmaceutical drugs for the treatment of autoimmune diseases | Health Technology |
Kesselman & Kesselman
Kesselman & Kesselman Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PricewaterhouseCoopers International Ltd.
PricewaterhouseCoopers International Ltd. Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax, legal, consulting and risk management services | Commercial Services |
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology Is a biopharmaceuticals company | Health Technology |
Y.L.R. Capital Markets Ltd. | |
Cellect Biotechnology Ltd.
Cellect Biotechnology Ltd. Medical SpecialtiesHealth Technology Develops biological products for cellular therapies | Health Technology |
- Stock Market
- Insiders
- Jonathan Burgin
















